
- Industry news
Industry news
- Category news
- Reports
- Key trends
- Multimedia
Multimedia
- Journal
- Events
- Suppliers
Suppliers
- Home
- Industry news
Industry news
- Category news
- Reports
- Key trends
- Multimedia
Multimedia
- Events
- Suppliers
Suppliers
SupplySide Global: Kerry’s biotic solutions for GLP-1 user side effect management
19 Nov 2025 | Kerry
At SupplySide Global 2025, Vivien Sheehan, VP of regional business development at Kerry, addressed the booming GLP-1 market and the need to manage side effects for users. She detailed Kerry’s studies on two biotics: the BC30 probiotic and the new Plenibiotic postbiotic for managing digestive discomfort. We explored how the company is combining best-in-class medical science with superior taste solutions.
Upcoming webinars

The future of infant nutrition: From science to success
Valio

From tiny guts to big impact: the powerful potential of probiotics in children’s health
Novonesis

Inside GLP-1 lives: real consumer insights to inspire innovation
FrieslandCampina Ingredients
















